CD1d-restricted glycolipid antigens: Presentation principles, recognition logic and functional consequences

Expert Reviews in Molecular Medicine

Volumn 10, Issue 20, 2008, Pages

  Florence, William C ^a   Bhat, Rakesh K ^a   Joyce, Sebastian ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; AUTOANTIGEN; CD1 ANTIGEN; CD14 ANTIGEN; CD1B ANTIGEN; CD1C ANTIGEN; CD1D ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GLYCEROLIPID; GLYCOLIPID; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LIPID; LIPOPOLYSACCHARIDE BINDING PROTEIN; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE BINDING PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; PATTERN RECOGNITION RECEPTOR; SURFACTANT PROTEIN A; T LYMPHOCYTE RECEPTOR; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; BACTERIAL IMMUNITY; BACTERIAL INFECTION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DESIGN; DRUG TARGETING; EHRLICHIA; ENDOCYTOSIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; INNATE IMMUNITY; LIPOGENESIS; LISTERIA; LYMPHOCYTE FUNCTION; MACROPHAGE; NATURAL KILLER T CELL; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; REVIEW; SALMONELLA; SIGNAL TRANSDUCTION; SPHINGOMONAS; STAPHYLOCOCCUS; STREPTOCOCCUS; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; CHEMISTRY; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; NATURAL KILLER CELL; NEOPLASM; PHENOTYPE; PHYSIOLOGY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD1; AUTOANTIGENS; AUTOIMMUNE DISEASES; CELL MEMBRANE; GLYCOLIPIDS; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; MODELS, BIOLOGICAL; NEOPLASMS; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL;

EID: 48949116965     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399408000732     Document Type: Review

References (152)

1. Bradstock, K.F. et al. (1980) Subpopulations of normal and leukemic human thymocytes: An analysis with the use of monoclonal antibodies. J Natl Cancer Inst 65, 33-42
2. McMichael, A.J. et al. (1979) A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol 9, 205-210
3. Martin, L.H. et al. (1987) Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c. Proc Natl Acad Sci U S A 84, 9189-9193
4. Martin, L.H., Calabi, F. and Milstein, C. (1986) Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc Natl Acad Sci U S A 83, 9154-9158
5. - cytolytic T lymphocytes. Nature 341, 447-450
6. - T lymphocytes to a microbial antigen. Nature 360, 593-597
7. + T cells. Nature 372, 691-694
8. Sieling, P.A. et al. (1995) CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230
9. Moody, D.B. et al. (2000) CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404, 884-888
10. Moody, D.B. et al. (2004) T cell activation by lipopeptide antigens. Science 303, 527-531
11. + T lymphocytes. Science 268, 863-865
12. - T cells. J Exp Med 180, 1171-1176
13. 8- α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCRα chain. J Exp Med 178, 1-16
14. - T cells. J Exp Med 186, 109-120
15. Cui, J. et al. (1997) Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626
16. Kawano, T. et al. (1997) CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626-1629
17. + NK T lymphocytes. J Immunol 161, 3271-3281
18. Brossay, L. et al. (1998) CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188, 1521-1528
19. Motsinger, A. et al. (2002) CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 195, 869-879
20. Motsinger, A. et al. (2003) Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells. J Virol 77, 8153-8158
21. Marks-Konczalik, J. et al. (2000) IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A 97, 11445-11450
22. - T cells in mice and humans. J Exp Med 180, 1097-1106
23. Bendelac, A., Savage, P.B. and Teyton, L. (2007) The biology of NKTcells. Annu Rev Immunol 25, 297-336
24. Brigl, M. and Brenner, M.B. (2004) CD1: Antigen presentation and T cell function. Annu Rev Immunol 22, 817-890
25. Trinchieri, G. and Sher, A. (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7, 179-190
26. Villadangos, J.A. and Schnorrer, P. (2007) Intrinsic and cooperative antigen-presenting functions of D1d-restricted glycolipid antigens: presentation principles, dendritic-cell subsets in vivo. Nat Rev Immunol 7, 543-555
27. Porcelli, S.A. (1995) The CD1 family: A third lineage of antigen-presenting molecules. Adv Immunol 59, 1-98
28. Van Kaer, L. (2005) α-Galactosylceramide therapy for autoimmune diseases: Prospects and obstacles. Nat Rev Immunol 5, 31-42
29. Spada, F.M., Koezuka, Y. and Porcelli, S.A. (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer Tcells. J Exp Med 188, 1529-1534
30. Kinjo, Y. et al. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525
31. Mattner, J. et al. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529
32. Sriram, V. et al. (2005) Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKTcells. Eur J Immunol 35, 1692-1701
33. Haygood, M.G. et al. (1999) Microbial symbionts of marine invertebrates: opportunities for microbial biotechnology. J Mol Microbiol Biotechnol 1, 33-43
34. Kinjo, Y. et al. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7, 978-986
35. Fischer, K. et al. (2004) Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A 101, 10685-10690
36. Ben-Menachem,G. et al. (2003) A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc Natl Acad Sci U S A 100, 7913-7918
37. Schroder, N.W. et al. (2003) Acylated cholesteryl galactoside as a novel immunogenic motif in Borrelia burgdorferi sensu stricto. J Biol Chem 278, 33645-33653
38. + targets. J Immunol 160, 3681-3688
39. Chiu, Y.H. et al. (1999) Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 189, 103-110
40. Chiu, Y.H. et al. (2002) Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat Immunol 3, 55-60
41. De Silva, A.D. et al. (2002) Lipid protein interactions: The assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum. J Immunol 168, 723-733
42. Stanic, A.K. et al. (2003) Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency. Proc Natl Acad Sci U S A 100, 1849-1854
43. Zhou, D. et al. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789
44. Brigl, M. et al. (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4, 1230-1237
45. Speak, A.O. et al. (2007) Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci U S A 104, 5971-5976
46. Li, Y. et al. (2008) Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry. Glycobiology 18, 158-165
47. Paget, C. et al. (2007) Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27, 597-609
48. Wu, D.Y. et al. (2003) Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 198, 173-181
49. Gumperz, J.E. et al. (2000) Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221
50. Rauch, J. et al. (2003) Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J Biol Chem 278, 47508-47515
51. Koch, M. et al. (2005) The crystal structure of human CD1d with and without α-galactosylceramide. Nat Immunol 6, 819-826
52. Zajonc, D.M. et al. (2005) Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol 6, 810-818
53. Zajonc, D.M. et al. (2005) Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med 202, 1517-1526
54. Zajonc, D.M. et al. (2006) Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d. J Immunol 177, 4577-4583
55. Giabbai, B. et al. (2005) Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: A molecular basis for NKT cell activation. J Immunol 175, 977-984
56. Wu, D. et al. (2006) Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A 103, 3972-3977
57. Zajonc, D.M. et al. (2008) Crystal structures of mouse CD1d-iGb3 complex and its cognate Vα14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids. J Mol Biol 377, 1104-1116
58. Amano, M. et al. (1998) CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: β2-microglobulin-dependent and independent forms. J Immunol 161, 1710-1717
59. Bradbury, A. et al. (1988) Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO J 7, 3081-3086
60. Brossay, L. et al. (1997) Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol 159, 1216-1224
61. Mandal, M. et al. (1998) Tissue distribution, regulation and intracellular localization of murine CD1 molecules. Mol Immunol 35, 525-536
62. Roark,J.H. et al. (1998) CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 160, 3121-3127
63. Dougan, S.K., Kaser, A. and Blumberg, R.S. (2007) CD1 expression on antigen-presenting cells. Curr Top Microbiol Immunol 314, 113-141
64. Kang, S.J. and Cresswell, P. (2002) Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J Biol Chem 277, 44838-44844
65. Zeng, Z. et al. (1997) Crystal structure of mouse CD1: An MHC-Like fold with a large hydrophobic binding groove. Science 277, 339-345
66. Park, J.J. et al. (2004) Lipid-protein interactions: Biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved. Proc Natl Acad Sci U S A 101, 1022-1026
67. Brozovic, S. et al. (2004) CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med 10, 535-539
68. Dougan, S.K. et al. (2007) MTP regulated by an alternate promoter is essential for NKT cell development. J Exp Med 204, 533-545
69. Dougan, S.K. et al. (2005) Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med 202, 529-539
70. Jayawardena-Wolf, J. et al. (2001) CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15, 897-908
71. Zhou, D. et al. (2004) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303, 523-527
72. Kang, S.J. and Cresswell, P. (2004) Saposins facilitate CD1d-restricted presentation of an exogerious lipid antigen to T cells. Nat Immunol 5, 175-181
73. Yuan, W. et al. (2007) Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc Natl Acad Sci U S A 104, 5551-5556
74. Schrantz, N. et al. (2007) The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J Exp Med 204, 841-852
75. Honey, K. et al. (2002) Thymocyte expression of cathepsin L is essential for NKT cell development. Nat Immunol 3, 1069-1074
76. + T cell selection and maturation by cathepsin S. Immunity 15, 909-919
77. Sagiv, Y. et al. (2007) A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d. J Exp Med 204, 921-928
78. Gadola, S.D. et al. (2006) Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J Exp Med 203, 2293-2303
79. van den Elzen, P. et al. (2005) Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437, 906-910
80. Van Kaer, L. and Joyce, S. (2006) Viral evasion of antigen presentation: not just for peptides anymore. Nat Immunol 7, 795-797
81. Sanchez, D.J., Gumperz, J.E. and Ganem, D. (2005) Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 115, 1369-1378
82. Chen, N. et al. (2006) HIV-1 down-regulates the expression of CD1d via Nef. Eur J Immunol 36, 278-286
83. Cho, S. et al. (2005) Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex. Virology 337, 242-252
84. Yuan, W, Dasgupta, A. and Cresswell, P. (2006) Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat Immunol 7, 835-842
85. Renukaradhya, G.J. et al. (2005) Virus-induced inhibition of CD1d1-mediated antigen presentation: Reciprocal regulation by p38 and ERK. J Immunol 175, 4301-4308
86. Roura-Mir, C. et al. (2005) Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2. J Immunol 175, 1758-1766
87. Gui, M. et al. (2001) TCRP chain influences but does not solely control autoreactivity of Vαl4Jα281 T cells. J Immunol 167, 6239-6246
88. Scott-Browne, J.P. et al. (2007) Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol 8, 1105-1113
89. Wang, J. et al. (1998) Atomic structure of an αβ T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody. EMBO J 17, 10-26
90. Ghendler, Y. et al. (1998) One of the CD3ε subunits within a T cell receptor complex lies in close proximity to the CO FG loop. J Exp Med 187, 1529-1536
91. Degermann, S., Sollami, G. and Karjalainen, K. (1999) T cell receptor P chain lacking the large solvent-exposed Cβ FG loop supports normal α/ β T cell development and function in transgenic mice. J Exp Med 189, 1679-1684
92. Sasada, T. et al. (2002) Involvement of the TCR Cβ FG loop in thymic selection and T cell function. J Exp Med 185, 1419-1431
93. Degermann, S., Sollami, G. and Karjalainen, K. (1999) Impaired NK1.1 T cell development in mice transgenic for a T cell receptor β chain lacking the large, solvent-exposed cβ FG loop. J Exp Med 190, 1357-1362
94. Stanic, A.K. et al. (2003) Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T (iNKT) cell receptor. J Immunol 171, 4539-4551
95. Cantu, C., 3rd et al. (2003) The paradox of immune molecular recognition of α-galactosylceramide: Low affinity, low specificity for CD1d, high affinity for αβTCRs. J Immunol 170, 4673-4682
96. Wedemayer, G.J. et al. (1997) Structural insights into the evolution of an antibody combining site. Science 276, 1665-1669
97. Wu, L.C. et al. (2002) Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature 418, 552-556
98. Feng, D. et al. (2007) Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat Immunol 8, 975-983
99. Borg, N.A. et al. (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448, 44-49
100. Sidobre, S. et al. (2002) The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J Immunol 169, 1340-1348
101. McCarthy, C. et al. (2007) The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med 204, 1131-1144
102. Grant, E.P. et al. (1999) Molecular recognition of lipid antigens by T cell receptors. J Exp Med 189, 195-205
103. Mehan, A. et al. (2000) Molecular recognition of human CD1b antigen complexes: Evidence for a common pattern of interaction with αβ TCRs. J Immunol 165, 4494-4504
104. Cantu, C., 3rd et al. (2003) The paradox of immune molecular recognition of α-galactosylceramide: Low affinity, low specificity for CD1d, high affinity for αβTCRs. J Immunol 170, 4673-4682
105. Gadola, S.D. et al. (2006) Structure and binding kinetics of three different human CD1d-α- galactosylceramide-specific T cell receptors. J Exp Med 203, 699-710
106. Kjer-Nielsen, L. et al. (2006) A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/ glycolipid recognition. J Exp Med 203, 661-673
107. Miyamoto, K., Miyake, S. and Yamamura, T. (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2 bias of natural killer T cells. Nature 413, 531-534
108. Yu, K.O. et al. (2005) Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc Natl Acad Sci U S A 102, 3383-3388
109. Germain, R.N. (2001) The art of the probable: System control in the adaptive immune system. Science 293, 240-245
110. Godfrey, D.I. and Berzins, S.P. (2007) Control points in NKT-cell development. Nat Rev Immunol 7, 505-518
111. MacDonald, H.R. and Mycko, M.P. (2007) Development and selection of Vαl4i NKT cells. Curr Top Microbiol Immunol 314, 195-212
112. + T cell receptor-α/β cells in the liver of mice. J Exp Med 180, 699-704
113. Stetson, D.B. et al. (2003) Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 198, 1069-1076
114. - T cells with a skewed variable region repertoire after infection with Listeria monocytogenes. Eur J Immunol 25, 1985-1991
115. + αβ T cells in IL-12 production during Salmonella infection. J Immunol 163, 2057-2063
116. Lee, P.T. et al. (2002) Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 110, 793-800
117. Wilson, M.T. et al. (2003) The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci U S A 100, 10913-10918
118. Crowe, N.Y. et al. (2003) Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 171, 4020-4027
119. Harada, M. et al. (2004) Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int Immunol 16, 241-247
120. Parekh, V.V. et al. (2005) Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 115, 2572-2583
121. Bezbradica, J.S. et al. (2005) Distinct roles of dendritic cells and B cells in Va14Ja18 natural (iNKT) cell activation in vivo. J Immunol 174, 4696-4705
122. Hayakawa, Y. et al. (2004) Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors. Nat Immunol 5, 590-596
123. Fujii, S. et al. (2002) Prolonged IFN-γ-producing NKT response induced with α- galactosylceramide-loaded DCs. Nat Immunol 3, 867-874
124. Fujii, S. et al. (2003) Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198, 267-279
125. Vincent, M.S. et al. (2002) CD1-dependent dendritic cell instruction. Nat Immunol 3, 1163-1168
126. Carnaud, C. et al. (1999) Cutting edge: Cross-talk between-cells of the innate immune system: NKT cells rapidly activate N-K cells. J Immunol 163, 4647-4650
127. Naumov, Y.N. et al. (2001) Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci U S A 98, 1838-13843
128. Nakagawa, R. et al. (2000) Antitumor activity of α-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells. Oncol Res 12, 51-58
129. Fujii, S. et al. (2004) The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199, 1607-1618
130. Diao, H. et al. (2004) Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21, 539-550
131. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171, 5140-5147
132. Singh, N. et al. (1999) Cutting edge: Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 163, 2373-2377
133. Forestier, C. et al. (2007) Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator. J Immunol. 178, 1415-1425
134. Ndonye, R.M. et al. (2005) Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH. J Org Chem 70, 10260-10270
135. Lee, P.T. et al. (2002) Distinct functional lineages of human Vα24 natural killer T cells. J Exp Med 195, 637-641
136. Gumperz, J.E. et al. (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195, 625-636
137. Crowe, N.Y. et al. (2005) Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 202, 1279-1288
138. Long, X. et al. (2007) Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids. Nat Chem Biol 3, 559-564
139. Salio, M. et al. (2007) Modulation of human natural killer T cell hgands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci U S A 104, 20490-20495
140. Park, S.-H., Roark, J.H. and Bendelac, A. (1998) Tissue-specific recognition of mouse CD1 molecules. J Immunol 160, 3128-3134
141. De Libero, G. et al. (2005) Bacterial infections promote T cell recognition of self-lipids. Immunity 22, 763-772
142. Nunnari, J. and Walter, P. (1996) Regulation of organelle biogenesis. Cell 84, 389-394
143. Cox, J.S., Chapman, R.E. and Walter, P. (1997) The unfolded protein response coordinates the production of ER protein and ER membrane. Mol Biol Cell 8, 1905-1914
144. Chapman, R., Sidrauski, C. and Walter, P. (1998) Intracellular signalling from the endoplasmic reticulum to the nucleus. Annu Rev Cell Biol. 14, 459-485
145. Brewer, J.W. and Hendershot, L.M. (2005) Building an antibody factory: A job for the unfolded protein response. Nature Immunol 6, 23-29
146. + T cells. Curr Opin Immunol 7, 367-374
147. Janeway, C.A. et al. (2001) Immunobiology: The Immune System in Health and Disease (5th edn), Garland Science, New York
148. Joyce, S. (2001) CD1d and natural T cells: How their properties jump-start the immune system. Cell Mol Life Sci 58, 442-469
149. Wilson, S.B. and Byrne, M.C. (2001) Gene expression in NKT cells: defining a functionally distinct CD1d-restricted T cell subset. Curr Opin Immunol 13, 555-561
150. Wilson, S.B. et al. (2000) Multiple differences in gene expression in regulatory Vα24JαQ T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci U S A 97, 7411-7416
151. Yu, K.O. et al. (2005) Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc Natl Acad Sci U S A 102, 3383-3388
152. Liu, N. et al. (2004) Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun 72, 3195-3203